Post by
SteadyHandsStan on Dec 07, 2016 9:53am
Its over for them...
RBC states the Pfizer-Flynn Decision as the reason for their downgrade this morning to UNDERPERFORM PRICE TARGET OF $1.00
WOW. Bondholders are likely now to stop the payment to Cinven in light of the CMA's decision, triggering a default and the capital structure to crumble. Karma to this drug gouger and kudos to the shorts who said five months ago that it would be the international part of the business that would cause them to file. Rather ironic, since they bought AMCO in the first place to reduce their drug pricing risk in the U.S. LMFA !
Comment by
KnowledgeSeekr8 on Dec 07, 2016 9:55am
Can you please let me know where to find the CMA news? I've searched and can't find anything from the past couple of days?
Comment by
serafin on Dec 07, 2016 12:07pm
This post has been removed in accordance with Community Policy
Comment by
KnowledgeSeekr8 on Dec 07, 2016 12:10pm
This is the fine for Pfizer and Flynn not Concordia. I didn't search news for another company. This doesn't necessarily mean that Concordia will face the same punishment. But its not good news either.
Comment by
GenericAdvocate on Dec 07, 2016 12:13pm
Get your head out of your a**